Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jamie L Todd

Showing results (21-30 of 72) with videos related to

Pageof 8
Sort By:
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 10, 2019
EGFR-Dependent IL8 Production by Airway Epithelial Cells After Exposure to the Food Flavoring Chemical 2,3-ButanedioneFrancine L Kelly, Kaitlyn E Weinberg, Andrew E Nagler, et al.
BMC Pulmonary Medicine|October 31, 2023
Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipientsAparna C Swaminathan, Richard Barfield, Mengqi Zhang, et al.
Clinical Trials (London, England)|November 11, 2017
Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.govIsaretta L Riley, L Ebony Boulware, Jie-Lena Sun, et al.
ERJ Open Research|June 24, 2025
Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosisJamie L Todd, Courtney Page, Peitao Wu, et al.
JHLT Open|March 27, 2025
Lung transplantation during acute exacerbations of interstitial lung disease and post-transplant survivalDaniel M Guidot, Jeremy M Weber, Aparna C Swaminathan, et al.
ERJ Open Research|July 28, 2022
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directionsAllan R Glanville, Christian Benden, Anne Bergeron, et al.
Lung|September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic TherapyJulia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
Respiratory Research|February 28, 2025
Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registryAparna C Swaminathan, Jeremy M Weber, Jamie L Todd, et al.
Respiratory Research|August 23, 2023
Lung function trajectories in patients with idiopathic pulmonary fibrosisMegan L Neely, Anne S Hellkamp, Shaun Bender, et al.
Plos One|October 17, 2024
Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO RegistryOlawale Amubieya, Jamie L Todd, Megan L Neely, et al.
Pageof 8

Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
Toxicological Sciences : an Official Journal of the Society of Toxicology|March 10, 2019
EGFR-Dependent IL8 Production by Airway Epithelial Cells After Exposure to the Food Flavoring Chemical 2,3-ButanedioneFrancine L Kelly, Kaitlyn E Weinberg, Andrew E Nagler, et al.
BMC Pulmonary Medicine|October 31, 2023
Prevalence and significance of clonal hematopoiesis of indeterminate potential in lung transplant recipientsAparna C Swaminathan, Richard Barfield, Mengqi Zhang, et al.
Clinical Trials (London, England)|November 11, 2017
Factors associated with reporting results for pulmonary clinical trials in ClinicalTrials.govIsaretta L Riley, L Ebony Boulware, Jie-Lena Sun, et al.
ERJ Open Research|June 24, 2025
Circulating prostasin is an independent marker of mortality risk in patients with idiopathic pulmonary fibrosisJamie L Todd, Courtney Page, Peitao Wu, et al.
JHLT Open|March 27, 2025
Lung transplantation during acute exacerbations of interstitial lung disease and post-transplant survivalDaniel M Guidot, Jeremy M Weber, Aparna C Swaminathan, et al.
ERJ Open Research|July 28, 2022
Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directionsAllan R Glanville, Christian Benden, Anne Bergeron, et al.
Lung|September 6, 2024
Utility of the 52-Gene Risk Score to Identify Patients with Idiopathic Pulmonary Fibrosis at Greater Risk of Mortality in the Era of Antifibrotic TherapyJulia F Söllner, Stefan Bentink, Christian Hesslinger, et al.
Respiratory Research|February 28, 2025
Extent of lung fibrosis is of greater prognostic importance than HRCT pattern in patients with progressive pulmonary fibrosis: data from the ILD-PRO registryAparna C Swaminathan, Jeremy M Weber, Jamie L Todd, et al.
Respiratory Research|August 23, 2023
Lung function trajectories in patients with idiopathic pulmonary fibrosisMegan L Neely, Anne S Hellkamp, Shaun Bender, et al.
Plos One|October 17, 2024
Associations of circulating matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases with clinically relevant outcomes in idiopathic pulmonary fibrosis: Data from the IPF-PRO RegistryOlawale Amubieya, Jamie L Todd, Megan L Neely, et al.
Pageof 8